We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...

October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...

From growing mini-organs to reviving the dodo and gene-editing embryos, boundaries between sci-fi and today's advances are ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

Endometriosis, an under-researched condition, has been rather difficult to treat with no cures to date. It is caused by the growth of tissue – similar to those in the uterine lining – outside the ...

A deficiency of dopamine: how does Parkinson’s disease affect the body? Unlike levodopa, which, when it reaches the brain gets converted to dopamine, the drug in question, tavapadon, activates ...

The global biotech industry is booming, and by 2025 it will reach an estimated market worth of $729B. But while great innovation is driven by emerging biotechs, these companies often lack resources, ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.